MyFinsight
Home
About
Contact
srpt: the income statement
Download
Download image
Unrealized gains on
investments, net of tax
$271K
(-91.73%↓ Y/Y)
Comprehensive (loss) income
-$179,676K
(-587.11%↓ Y/Y)
Total other
comprehensive income
$271K
(-91.73%↓ Y/Y)
Revenue From Contract
With Customer...
$131,498K
Rest Of World
$29,413K
US
$209,132K
Net (loss) income
-$179,947K
(-635.38%↓ Y/Y)
Income tax (benefit)
expense
-$14,102K
(-3670.13%↓ Y/Y)
Elevidys
$131,498K
Pmo Products
$238,545K
(loss) income before
income tax (benefit)...
-$194,049K
(-670.63%↓ Y/Y)
Collaboration and other
$29,313K
(-21.63%↓ Y/Y)
Products, net
$370,043K
(-13.90%↓ Y/Y)
Total other (loss)
income, net
-$90,660K
(-867.65%↓ Y/Y)
Operating (loss) income
-$103,389K
(-565.80%↓ Y/Y)
Other income, net
$47,953K
(306.04%↑ Y/Y)
Total revenues
$399,356K
(-14.52%↓ Y/Y)
Loss on debt
extinguishment
-$138,613K
Total cost and
expenses
$502,745K
(12.98%↑ Y/Y)
Amortization of in-licensed
rights
$677K
(12.46%↑ Y/Y)
Restructuring charges
$40,510K
Selling, general and
administrative
$91,893K
(-28.32%↓ Y/Y)
Research and development
$218,890K
(-2.49%↓ Y/Y)
Cost of sales
(excluding amortization of...
$150,775K
(64.44%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)